Posted by Michael Wonder on 27 Sep 2023
Expanded medicines for breast cancer and leukaemia on the PBS
26 September 2023 - From 1 September 2023, Australians with an aggressive form of breast cancer and certain types of leukaemia will have access to new treatment options under the PBS.
The life changing treatment Pembrolizumab (Keytruda) is being expanded to patients with locally recurrent unresectable or metastatic triple negative breast cancer that expresses a particular protein called PD-L1.
